Skip to main content
. 2022 Jul 18;12(7):195–203. doi: 10.5500/wjt.v12.i7.195

Table 2.

Preoperative, intraoperative, and post-operative characteristics

Preoperative
Brustia et al[8]
Xu et al[9]
Rao et al[7]

ERAS group, n = 10
CONTROL group, n = 20
ERAS group, n = 40
CONTROL group, n = 53
ERAS group, n = 54
CONTROL group, n = 74
Gender
Male 8 17 35 46 40 58
Female 2 3 5 7 1 16
Age, yr 60.1 (52.5-66.1) 58.2 (52.6-65.3) 49.5 (40-56.8) 53 (47-59) 52.4 + 15.2 55.8 + 14.3
Primary cause
Alcohol 7 (70%) 9 (45%) 7 3 6 (11.1) 10 (13.5)
Viral cirrhosis 7 (70%) 10 (50%) 11 16 30 (55.6) 40 (54.1)
HBV 2 (20%) 4 (20%) NA NA NA NA
HCV 6 (60%) 8 (40%) NA NA NA NA
Metabolic syndrome 2 (20%) 4 (20%) NA NA NA NA
Biliary disease 0 3 (15%) NA NA NA NA
HCC 9 (90%) 9 (45%) 17 24 18 (33.3) 24 (32.4)
MELD score 7 (6-10) 7 (6-9) 14 (9-22) 17 (14-19) 7.7 + 3.2 7.9 + 4.6
Intraoperative
Operative time 6.0 (5.9-8.4) h 6.7 (5.7-8.2) h 443.7 + 85.3min 453.5 + 62.3min 265 (215-360) min 325 (275-455) min
Anhepatic period NA NA 44.3 + 5.2 min 42.7 + 4.2 min 45 (35-70) min 60 (50-75) min
Blood loss NA NA 775 (525-1000) mL 800 (600-1000) mL 1100 (300-4200) mL 2900 (1600-7000) mL
Hypothermia during the operation (n, %) NA NA 0 12% 0 0
Postoperative
Early extubation (h) 2 (0-2) 7.5 (4.5-13.0) 0 6 (5.5-8) NA NA
ICU stay (d) 3 (2-4) 4.5 (3.0-8.3) 2 (2-3) 4 (4-5) 2 (1-7) 5 (3-15)
Complications (n, %) 5 (50%) 16 (80%) 9 (22.5%) 26 (49.1%) 10 (18.5%) 20 (27%)
Pain score after operation 3 (1.0-4.0) POD 4.5 (2.7-6.) POD 2.45+ 0.54 3.02+0.44 NA NA
Postoperative hospital stay (d) 9.5 (9.0-10.5) 18 (14.3-24.3) 14.5 (12-17) 16 (15-18) 18 (15-32) 28 (23-35)
Readmission within 30 d after discharge NA NA 0 0 0 0

Categorical variables are reported using percentages; continuous variables are summarized using median and 25%-75% percentiles. ERAS: Enhanced recovery after Surgery; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; ICU: Intensive care unit; MELD: Model for end-stage liver disease.